Sucralfate Tablets - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Corebridge Financial (NYSE: CRBG) and Equitable Holdings (NYSE: EQH) announce $22bn all-stock merger to create $1.5tn retirement and asset management giant

Is Firefly Neuroscience, Inc. building a scalable AI diagnostics platform through U.S. defense healthcare partnerships? (NASDAQ: AIFF)

Enerpac Tool Group (NYSE: EPAC) posts 10-quarter-high product growth as EMEA service slump and $51m buyback reshape its fiscal 2026 outlook

Representative image of United States President Donald Trump issuing a 48-hour ultimatum to Iran over the Strait of Hormuz, highlighting escalating tensions and threats to target Iranian power plants.

Trump warns Iran to get serious on ceasefire as Tehran rejects US 15-point peace proposal

Zydus Lifesciences gets FDA final approval for Sucralfate Tablets

Read More

1 minute read

Pharma Industry News

Zydus Lifesciences gets FDA final approval for Sucralfate Tablets

Zydus Lifesciences has bagged final approval to manufacture and market Sucralfate Tablets USP, 1 gram from the US…

byPallavi Madhiraju

May 7, 2023

web analytics